XTX Topco’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

XTX Topco’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31K	Buy	+17,639	New	+$28.4K	﹤0.01%	3819

Other funds holding SXTP

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

XTX Topco's SXTP Position: Q2 2026 in Review

XTX Topco opened a new position in 60 Degrees Pharmaceuticals (SXTP) in Q2 2026: 17,639 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #3819 among its holdings.

8 funds tracked by Wall St. Rank hold SXTP as of Q2 2026.

XTX Topco held 17,639 shares of 60 Degrees Pharmaceuticals worth $31K as of Q2 2026.
60 Degrees Pharmaceuticals was a new XTX Topco position in Q2 2026.
60 Degrees Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3819 holding.
8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.